In our second ASCO highlights post, we discuss the promising potential of liquid biopsy and comprehensive genotyping in precision oncology, and new indications for Keytruda.
In our first of two ASCO 2020 posts, we discuss clinical data from an off-the-shelf CAR-T therapy, and look at how real-world evidence can be used to help physicians improve outcomes for their cancer patients in ways beyond cancer treatment itself.
While some pharma and biotech companies are struggling during the COVID-19 pandemic, others are thriving thanks to government grants, joint research initiatives and venture capital.